Pharmaceuticals

Check out this new product as part of our full October drug news overview.

The funding will support the creation of the Canadian Drug Supply Observatory, a national hub that will study medication supply risks.

We examined what happens to the appropriateness, quantity and cost of prescriptions when doctors accept payments or meals from the pharmaceutical industry. The result is not good news for patients.

The rule applies to a swath of goods beyond drugs and is intended to collect tariffs and prevent illegal drugs from coming into the U.S.

Study assesses whether holding certain DMARD therapy for two weeks after COVID-19 vaccination improves vaccine immunogenicity or worsens arthritis disease activity.

A full overview of new therapies, indications, Health Canada advisories, new generics and more.

The booming natural health market escapes the heavy scrutiny of prescription medications. It’s time that changed.

Pharmacies and healthcare providers are facing rising drug costs and uneven supplies as sanctions and import disruptions make some medicines harder to find.

The newly approved inhaler combines three COPD medications in a single device for long-term maintenance treatment.

The Canadian Thoracic Society has issued updated, evidence-based recommendations for the pharmacologic management of severe asthma in children, adolescents and adults.